Launch sequencing of pharmaceuticals with multiple therapeutic indications: evidence from seven countries

BACKGROUND: New medicines are increasingly being identified as efficacious across multiple indications. The impact of current pricing and reimbursement policies on launch decisions across these indications remains unclear. OBJECTIVE: This paper, first, maps marketing authorisation and HTA coverage r...

Descripción completa

Detalles Bibliográficos
Autores principales: Mills, Mackenzie, Michaeli, Daniel, Miracolo, Aurelio, Kanavos, Panos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9923892/
https://www.ncbi.nlm.nih.gov/pubmed/36782175
http://dx.doi.org/10.1186/s12913-023-09095-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9923892/
https://www.ncbi.nlm.nih.gov/pubmed/36782175
http://dx.doi.org/10.1186/s12913-023-09095-2

Ejemplares similares